“…pruritus, vertigo, shaking, malaise, angina, bronchospasm, nausea, vomiting, abdominal pain, melaena) (64,67) Cutaneous lesions at some distance from the application zone (37,38) Marked reduction of FEV1 (51-53) Shock and cardio-respiratory failure (68) Photo contact allergy (42) Bronchospasm, bronchoconstriction (52, 53) Generalized maculo-erythematous or eczematous eruption (54) Diffuse pruritus (29) Urticaria, angioedema (29,55) Allergic reaction in subjects not themselves treated by inhalers, but responsible for or living with patients who use inhalers regularly (56) Allergic hypersensitivity to topical and systemic corticosteroids multi-centre European study has shown that more than 50% of patients with an allergy to tixocortol pivalate were not detected with this mix (75), presumably due to masking by the anti-inflammatory effect of the other constituents. This method cannot therefore replace testing with individual markers.…”